Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of first-line immunotherapies for advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences